![](https://investorshub.advfn.com/uicon/158678.png?cb=1661594561)
Monday, November 26, 2018 2:13:40 PM
It doesn't answer this question, though, in terms of IPIX.:
"I wonder if such a thing fits the FDA's meeting rules."
If anything it suggests that the FDA may not let IPIX bring a plus one.
Per the example....
The Developer said to the 3 BPs with a special interest: "if they’d like a seat at the table for the EOP2 meeting with FDA, then term sheets are due by X date, and full contract must be executed by Y date."
A full contract at the time of the Meeting would clearly establish that the BP was a party that the FDA could consider to be "from the requester’s organization", thereby justifying their presence at the meeting. That full contract is what that Developer sought and in fact demanded prior to the meeting.
Currently, as far as I know (and I think it's consistent with all the publicly released information) IPIX has "only" signed a non-binding term sheet and as I understand it it includes an indication (IBD/UP) that isn't a subject of the meeting at all. One thing that is obvious from the Guidance pdfs is that the FDA takes these meetings seriously, demanding that the package provide the focal points and the areas the Developer hopes to have addressed and the amount of time they expect each topic to take. A full contract provides the FDA comfort that they don't have a participant at the meeting posing questions and using their valuable time, that may turn out to have simply been a looky-loo.
ps. Where can I find this SitTight person?
pps. Obviously some record of an EOP2 sponsor enjoying the company of a BP prior to the execution of a full agreement at their end of phase meeting would be welcome.
...and because it's interesting, part one:
https://www.locustwalk.com/time-will-kill-your-dealbut-in-deal-making-timing-is-everything-part-one/
But can it core A apple?
Yes Ralph, of course it can core A apple.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM